{'52WeekChange': -0.63756096,
 'SandP52WeekChange': None,
 'address1': '200 Berkeley Street',
 'address2': '19th Floor',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 8.68,
 'askSize': 1300,
 'averageDailyVolume10Day': 83512,
 'averageVolume': 63463,
 'averageVolume10days': 83512,
 'beta': None,
 'beta3Year': None,
 'bid': 7.12,
 'bidSize': 1100,
 'bookValue': None,
 'category': None,
 'circulatingSupply': None,
 'city': 'Boston',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 7.4199,
 'dayLow': 7.0228,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': None,
 'enterpriseToRevenue': None,
 'enterpriseValue': 134743616,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 9.0035715,
 'fiftyTwoWeekHigh': 30,
 'fiftyTwoWeekLow': 5.95,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 2477074,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fullTimeEmployees': 12,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.02678,
 'heldPercentInstitutions': 0.022720002,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1577750400,
 'lastSplitFactor': '1:25',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/neurobopharma.com',
 'longBusinessSummary': 'NeuroBo Pharmaceuticals, Inc., a clinical-stage '
                        'biotechnology company provides therapies for '
                        'neurodegenerative and cardiometabolic diseases. Its '
                        'therapeutics programs include NB-01 for the treatment '
                        'of painful diabetic neuropathy; NB-02 to treat '
                        'cognitive impairment and modify the progression of '
                        'neurodegenerative diseases associated with the '
                        'malfunction of protein; and Gemcabene, which is '
                        'focused on developing and commercializing therapies '
                        'for the treatment of dyslipidemia. NeuroBo '
                        'Pharmaceuticals, Inc. was incorporated in 2017 and is '
                        'headquartered in Boston, Massachusetts.',
 'longName': 'NeuroBo Pharmaceuticals, Inc.',
 'market': 'us_market',
 'marketCap': 118276560,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_630763379',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1561852800,
 'navPrice': None,
 'netIncomeToCommon': -23578000,
 'nextFiscalYearEnd': 1640908800,
 'open': 7.35,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '857 702 9600',
 'previousClose': 7.43,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 7.4199,
 'regularMarketDayLow': 7.0228,
 'regularMarketOpen': 7.35,
 'regularMarketPreviousClose': 7.43,
 'regularMarketPrice': 7.35,
 'regularMarketVolume': 45340,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 16427300,
 'sharesPercentSharesOut': 0.012200001,
 'sharesShort': 200805,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 63137,
 'shortName': 'NeuroBo Pharmaceuticals, Inc.',
 'shortPercentOfFloat': 0.044499997,
 'shortRatio': 2.54,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'NRBO',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 12.460374,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'df3dac6a-eed3-3175-b85d-a432fd732c3e',
 'volume': 45340,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.neurobopharma.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '02116'}